| Date Filed | Type | Description |
| 10/05/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 04/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 03/06/2023 |
10-K/A
| Annual Report for the period ended August 31, 2022 [amend] |
| 03/06/2023 |
10-Q/A
| Quarterly Report for the period ended November 30, 2022 [amend] |
| 02/08/2023 |
10-K/A
| Annual Report for the period ended August 31, 2022 [amend] |
| 12/14/2022 |
10-K
| Annual Report for the period ended August 31, 2022 |
| 11/28/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 10/31/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 07/27/2022 |
8-K
| Quarterly results |
| 07/20/2022 |
10-Q
| Quarterly Report for the period ended May 31, 2022 |
| 07/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/04/2022 |
QUALIF
| Form QUALIF - Notice of Qualification [Regulation A]: |
| 04/28/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Forward Purchase Agreement between CPHARMACEUTICA DISTRIBUIDORA DE PRODUTOS MEDICOS LTDA and Allied Corp",
"ALLIED CORP ANNOUNCES INITIAL US$147,000 PURCHASE ORDER CONTINUING INTO MONTHLY SUPPLY AGREEMENT FOR BRAZILIAN SPECIALTY CANCER CARE HOSPITAL Kelowna, BC, Canada – April 27, 2022 Allied Corp . is pleased to announce the signing of a forward purchase agreement with a distributor for a specialty medical care hospital based out of Sao Paulo, Brazil. Under this agreement, the Brazilian Group will initially purchase US$147,000 worth of Allied products that will continue on a monthly basis. The products from the purchase order will focus on specialty medical care for tens of thousands of Brazilian oncology patients. The hospital that the products are intended for was founded in 1971 with the mission of providing quality health care, generating knowledge, and promoting social responsibility. The..." |
|
| 04/25/2022 |
1-A/A
| Form 1-A/A - Offering Statement [Regulation A]: [Amend] |
| 04/18/2022 |
10-Q
| Quarterly Report for the period ended February 28, 2022 |
| 04/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/06/2022 |
1-A
| Form 1-A - Offering Statement [Regulation A]: |
| 01/19/2022 |
10-Q
| Quarterly Report for the period ended November 30, 2021 |
| 01/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 12/14/2021 |
10-K
| Annual Report for the period ended August 31, 2021 |
| 12/07/2021 |
8-K
| Quarterly results |
| 11/29/2021 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 11/15/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/14/2021 |
1-A-W
| Form 1-A-W - Withdrawal of offering statement [Regulation A]: |
| 08/23/2021 |
1-A/A
| Form 1-A/A - Offering Statement [Regulation A]: [Amend] |
| 07/20/2021 |
10-Q
| Quarterly Report for the period ended May 31, 2021 |
| 07/15/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 06/14/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 06/11/2021 |
1-A
| Form 1-A - Offering Statement [Regulation A]: |
| 05/18/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/18/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
|